• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非 ST 段抬高急性冠状动脉综合征中自我报告的虚弱与预后的关系:来自 TRILOGY ACS 试验的观察。

Sex And Prognostic Significance of Self-Reported Frailty in Non-ST-Segment Elevation Acute Coronary Syndromes: Insights From the TRILOGY ACS Trial.

机构信息

Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada; Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.

出版信息

Can J Cardiol. 2019 Apr;35(4):430-437. doi: 10.1016/j.cjca.2018.12.035. Epub 2018 Dec 31.

DOI:10.1016/j.cjca.2018.12.035
PMID:30935633
Abstract

BACKGROUND

The effect of sex on self-reported frailty in acute coronary syndromes (ACS) is unclear. We examined the prevalence of self-reported frailty and its association with all-cause death among men and women.

METHODS

Elderly (≥ 65 years) male (n = 2691) and female (n = 2305) patients with ACS enrolled in the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial were screened using the Fried Frailty Index. Sex differences in prevalence of frailty symptoms and categories (not frail; prefrail [1 to 2 symptoms]; and frail [≥ 3 symptoms]) and their prognostic importance were examined.

RESULTS

Women were older and had higher rates of comorbidities than men. A total of 739 (27.5%) men and 645 (28%) women reported ≥ 1 frailty symptom. Prevalence of frailty increased with age among men but not women. During a median follow-up of 17.3 months, 353 (13.1%) men and 266 (11.5%) women died. After adjusting for age, prefrail men had a 35% increased risk (hazard ratio [HR] 1.35; 95% confidence interval [CI], 1.07-1.71), and frail men had an 80% increased risk (HR 1.80; 95% CI, 1.22-2.67) of death relative to not-frail men. The age-adjusted HR for death in prefrail women was 1.40 (95% CI, 1.07-1.84), and 1.55 (95% CI, 0.96-2.49) in frail women relative to not-frail women. Self-reported slow walk time and decreased physical activity appeared to provide the most prognostic information.

CONCLUSION

Self-reported frailty was similar among men and women with ACS. Frailty increased with age only among men, in whom it added more prognostic information. Patient-reported frailty may identify elderly patients with ACS, particularly men, at high-risk of mortality.

摘要

背景

性别的影响对急性冠状动脉综合征(ACS)患者的自我报告虚弱程度并不明确。我们检测了男女患者中自我报告虚弱的患病率及其与全因死亡率的相关性。

方法

入选参与靶向血小板抑制以明确急性冠状动脉综合征最佳药物治疗策略(TRILOGY ACS)试验的≥ 65 岁的老年男性(n=2691)和女性(n=2305)患者,使用 Fried 虚弱指数进行筛选。分析衰弱症状的流行率及其类别(无虚弱;虚弱前期[1-2 个症状];虚弱[≥3 个症状])在性别上的差异,以及它们的预后意义。

结果

女性患者年龄更大且合并症发生率更高。共有 739 例(27.5%)男性和 645 例(28%)女性报告≥1 个虚弱症状。男性患者的虚弱患病率随年龄增长而增加,但女性患者无此趋势。在中位随访 17.3 个月期间,353 例(13.1%)男性和 266 例(11.5%)女性死亡。在调整年龄后,虚弱前期男性的死亡风险增加了 35%(危险比[HR]1.35;95%置信区间[CI],1.07-1.71),虚弱男性的死亡风险增加了 80%(HR 1.80;95% CI,1.22-2.67),与非虚弱男性相比。虚弱前期女性的死亡风险调整后 HR 为 1.40(95% CI,1.07-1.84),而虚弱女性的 HR 为 1.55(95% CI,0.96-2.49),与非虚弱女性相比。自我报告的慢走时间和体力活动减少似乎提供了最具预后意义的信息。

结论

ACS 患者中,自我报告的虚弱程度在男性和女性之间相似。虚弱仅在男性中随年龄增加而增加,在男性中虚弱增加了更多的预后信息。患者报告的虚弱可能会识别出 ACS 老年患者,尤其是男性,他们具有更高的死亡率风险。

相似文献

1
Sex And Prognostic Significance of Self-Reported Frailty in Non-ST-Segment Elevation Acute Coronary Syndromes: Insights From the TRILOGY ACS Trial.非 ST 段抬高急性冠状动脉综合征中自我报告的虚弱与预后的关系:来自 TRILOGY ACS 试验的观察。
Can J Cardiol. 2019 Apr;35(4):430-437. doi: 10.1016/j.cjca.2018.12.035. Epub 2018 Dec 31.
2
Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.衰弱与非ST段抬高型急性冠状动脉综合征的不良预后相关:来自“旨在明确急性冠状动脉综合征药物治疗最佳策略的靶向血小板抑制(TRILOGY ACS)试验”的见解。
Eur Heart J Acute Cardiovasc Care. 2016 Jun;5(3):231-42. doi: 10.1177/2048872615581502. Epub 2015 Apr 20.
3
Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial.不稳定型心绞痛/非ST段抬高型心肌梗死患者未经血运重建而接受药物治疗时,女性与男性的长期预后:来自“旨在明确药物治疗急性冠脉综合征的最佳策略的靶向血小板抑制”(TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes)试验的见解
Am Heart J. 2015 Oct;170(4):695-705.e5. doi: 10.1016/j.ahj.2015.06.011. Epub 2015 Jun 20.
4
Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes.存活天数与出院情况:在急性冠脉综合征患者的临床试验中探索以患者为中心的务实结局
Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e004755. doi: 10.1161/CIRCOUTCOMES.118.004755.
5
Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial).初始药物治疗非 ST 段抬高型急性冠脉综合征(TRILOGY ACS 试验)患者接受下游血运重建的结局。
Am J Cardiol. 2018 Oct 15;122(8):1322-1329. doi: 10.1016/j.amjcard.2018.06.052. Epub 2018 Jul 19.
6
Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial.普拉格雷与氯吡格雷对急性冠脉综合征后长期卒中风险的时变效应:TRILOGY ACS试验结果
Stroke. 2016 Apr;47(4):1135-9. doi: 10.1161/STROKEAHA.115.012454. Epub 2016 Feb 16.
7
Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial.普拉格雷用于药物治疗的非ST段抬高型急性冠状动脉综合征患者的健康相关生活质量结局:来自“靶向血小板抑制以明确药物治疗急性冠状动脉综合征的最佳策略(TRILOGY ACS)”试验的见解。
Am Heart J. 2016 Aug;178:55-64. doi: 10.1016/j.ahj.2016.03.017. Epub 2016 Apr 16.
8
Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial.极低水平高密度脂蛋白胆固醇与未行血运重建治疗的急性冠脉综合征患者长期预后的关联:来自TRILOGY ACS试验的见解
Clin Cardiol. 2016 Jun;39(6):329-37. doi: 10.1002/clc.22533. Epub 2016 May 13.
9
An Easy Assessment of Frailty at Baseline Independently Predicts Prognosis in Very Elderly Patients With Acute Coronary Syndromes.基线时简易虚弱评估独立预测急性冠状动脉综合征超高龄患者预后。
J Am Med Dir Assoc. 2018 Apr;19(4):296-303. doi: 10.1016/j.jamda.2017.10.007. Epub 2017 Nov 17.
10
Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy.ACS 患者未血运重建治疗时应用普拉格雷和氯吡格雷延长疗程的血小板功能:TRILOGY ACS 血小板功能亚研究。
JAMA. 2012 Nov 7;308(17):1785-94. doi: 10.1001/jama.2012.17312.

引用本文的文献

1
Evidence paradox: Enhancing clinical trials for older adults.证据悖论:加强针对老年人的临床试验
J Nutr Health Aging. 2025 Jun;29(6):100597. doi: 10.1016/j.jnha.2025.100597. Epub 2025 Jun 10.
2
Association Between Handgrip Strength and Mortality of Patients With Coronary Artery Disease: A Meta-Analysis.握力与冠心病患者死亡率的关系:一项荟萃分析。
Clin Cardiol. 2024 Jul;47(7):e24322. doi: 10.1002/clc.24322.
3
Symptom recognition and treatment-seeking behaviors in women experiencing acute coronary syndrome for the first time: a qualitative study.
首次发生急性冠状动脉综合征的女性的症状识别与就医行为:一项定性研究
BMC Cardiovasc Disord. 2022 Nov 28;22(1):508. doi: 10.1186/s12872-022-02892-3.
4
Optimal dual antiplatelet therapy strategy in elderly patients with acute coronary syndrome.老年急性冠状动脉综合征患者的最佳双联抗血小板治疗策略
J Geriatr Cardiol. 2021 Mar 28;18(3):210-218. doi: 10.11909/j.issn.1671-5411.2021.03.010.